Clinical Research Directory

Inclusion Criteria: * Age ≥18 years * Diagnosis history of CIPN of lower extremities * Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of SCS * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Patients undergoing active chemotherapy or immunotherapy * Patients undergoing medical litigation. * Patients with active infection, being treated with antibiotics * Patients that are pregnant or planning to conceive * Patients who are receiving any investigational agents. * Patients with brain metastases. * Patients with cognitive impairment/psychiatric illness/social situations that would limit compliance with study requirements. * Patients with history of alternative forms of sensorimotor neuropathies prior to CIPN presentation